March 18, 2020 — Our toll-free FAA medical certification hotline (888-LEFTSEAT) is fielding inquiries from airman seeking aeromedical guidance concerning COVID-19.

While this illness, and other medical conditions caused by the Coronavirus, may not be listed as disqualifying in the Federal Aviation Regulations (FAR’s), there are several potentially jeopardizing issues which can delay or prevent FAA medical certification.

The COVID-19 pandemic has resulted in access problems to the FAA, FAA Designated Aviation Medical Examiners and other medical specialists. It is more important than ever to make absolutely sure that your medical records are squared-away and customized to satisfy the FAA. This can alleviate delays and in some cases even avoid time consuming steps. The FAA has announced that they will not take enforcement action against airmen for the use of airman medical certificates which expire between the dates of March 31, 2020 and June 30, 2020. We will continue to work closely with our clients and the FAA to assist airman with medical certification issues.

If you have been you have been asked to provide additional medical information and your treating physician or other clinician is unavailable, we can help you file an extension. Pilot Medical Solutions has extensive experience with FAA medical certification matters. Let us keep you flying.

Pilots seeking FAA medical certification after Coronavirus (COVID-19) will require complete recovery from the Coronavirus and an eloquent detailed review of any other system which may have been affected by this virus. Again, while COVID-19 is not specifically listed as disqualifying in the FAR’s, Federal Aviation Regulations do require pilots to ground themselves if they know or have reason to know of any medical condition or treatment that makes them unable to operate an aircraft in a safe manner. The Coronavirus often affects the lungs and this is an example of how a secondary condition may add to the FAA requirements for pilot certification after COVID-19 infection. Pilots whose lungs were involved will likely need at least pulmonary function testing (PFT’s).

The FDA has approved Plaquenil (Hydroxychloroquine) to treat COVID-19. It is not new. In fact Plaquenil has been used to treat other conditions since 1955. There is controversy over the effectiveness, both for prevention and treatment of COVID-19, and most believe additional studies are needed to establish the efficacy of this drug. The COVID pandemic has reduced the availability of Plaquenil which has resulted in substantial alarm. Pharmacy boards across the US have limited its availability to those requiring it for previously labeled conditions such as the treatment of Lupus and rheumatoid arthritis.

Physicians have been prescribing Plaquenil for many years in order to prevent malaria. The FAA requires pilots taking Plaquenil to be free of adverse effects from the drug. This should include an eye evaluation because in some cases this drug can affect or even permanently damage vision. Contact us to find out how to eloquently document and carefully submit medical records to the FAA. DOT / FAA Safety Alert Guidance for COVID-19 can be downloaded here.

If you suspect that you are not well it is best to isolate yourself as much as possible and consult your private physician, local health department or medical center via telephone. If you experience an emergency condition call 911.

In order to help pilots in differentiating between the common cold, flu and Coronavirus, we have posted the New Jersey department of public health info-graphic which provides practical Coronavirus guidance.

Additional COVID-19 guidance can be obtained from the links below.
FAA Facilities affected by COVID-19
David Price, MD, Cornell Medical Center, NY, 3/22/2020
FAA COVID19 FAA Medical Extension

Contact us at 1-800-699-4457 or by email here
to confidentially discuss your FAA medical issues.